Learn More About the PROSERA Study
Now enrolling: The PROSERA phase 3 study of seralutinib in adults with pulmonary arterial hypertension.
Understanding Drivers and Barriers to Participation in Clinical Trials for Patients with Pulmonary Arterial Hypertension (PAH)